Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 254
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01840150 | Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer | ||
| NCT03113071 | Safety and Activity of Digoxin With Decitabine in Adult AML and MDS | ||
| NCT00700778 | Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations | ||
| NCT06089954 | Penn Medicine Biobank Return of Results Program | ||
| NCT03177057 | SMART Project in Preventing Skin Cancer | ||
| NCT02609230 | A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma | ||
| NCT05427240 | eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer | ||
| NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | ||
| NCT01726296 | Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care | ||
| NCT00397982 | Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma | ||
| NCT07663422 | Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy | ||
| NCT06476938 | Testing Gene PilotLX With Latinx Cancer Patients | ||
| NCT01962948 | Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT01059552 | Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT00352638 | Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer | ||
| NCT06396533 | Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) | ||
| NCT03930797 | Coping Together After Breast Cancer | ||
| NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | ||
| NCT00816374 | Tailored Intervention for Melanoma Patient's Families | ||
| NCT00039520 | Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | ||
| NCT07638410 | Prehabilitation in High-risk Oncologic Surgery | ||
| NCT05800587 | Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer | ||
| NCT03099499 | Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer | ||
| NCT02535247 | Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma | ||
| NCT04381806 | Phase I Study in Advanced Malignancies With 5-ALA | ||
| NCT07517666 | Genetic Information for Families After Tumor Testing Study | ||
| NCT01316757 | Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer | ||
| NCT00022711 | Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer | ||
| NCT07221942 | Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma | ||
| NCT03095209 | Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery | ||
| NCT06218628 | Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition | ||
| NCT00062296 | Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | ||
| NCT01068769 | Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor | ||
| NCT00509626 | Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy | ||
| NCT07072312 | Feasibility, Acceptability and Fidelity of Integrating a Navigation Intervention Into Tobacco Treatment Program | ||
| NCT03179943 | Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma | ||
| NCT00582829 | Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients | ||
| NCT05400577 | Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC | ||
| NCT00322296 | Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis | ||
| NCT05800574 | Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer | ||
| NCT00350025 | Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer | ||
| NCT04668768 | HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma | ||
| NCT00087360 | Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants | ||
| NCT01561326 | Facilitating Follow-Up Adherence for Abnormal Pap Smears | ||
| NCT00394147 | Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer | ||
| NCT07471958 | Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3) | ||
| NCT02143115 | Comparative Effectiveness of CTC & OC | ||
| NCT01539174 | Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma | ||
| NCT00003943 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | ||
| NCT00084513 | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer |
